FDA recall, , Moderate risk
Arjo Tenor Mobile Passive Patient Lift
The Arjo Tenor mobile passive patient lift has an internal actuator component that may not meet required mechanical strength.
Summary by Recall Canary from the FDA notice
What happened
ArjoHuntleigh Polska Sp. z.o.o., located in Komorniki, Poland, began a recall of the Arjo Tenor mobile passive patient lift on March 10, 2026. The FDA added the recall to its Enforcement Report on April 10, 2026, and it was listed in the weekly enforcement report on April 22, 2026. The recall involves 119 units distributed nationwide in the US.
The agency stated that an internal component of the actuators in a certain production batch may not meet the required mechanical strength, which could result, in the worst case scenario, in a sudden loss of the actuator's ability to hold the load, leading to rapid and uncontrolled downward movement of the lifting arm.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:
- A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
- Talk to your health care provider before you stop using it.
Is yours affected?
Affected if its UDI-DI is listed.
A UDI-DI is the device identifier printed with the barcode on the device label.
Arjo Tenor mobile passive patient lift
- UDI-DI
- 05055982787758
- 05055982787710
- Model number
- KHA1000 USKHA1010 US
Recall details
- Company began the recall
- Sold in
US Nationwide distribution.
- Company
- ARJOHUNTLEIGH POLSKA Sp. z.o.o.Komorniki, Poland
- Hazard
- Device defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98542
- Recall number
- Z-1811-2026
- Quantity recalled
- 119 units
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
In FDA's weekly enforcement report
Listed on Recall Canary
Summary updated
